hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours

British Journal of Cancer

Volumn 96, Issue 5, 2007, Pages 762-768

  Nutt, J E ^a   Foster, P A ^a   Mellon, J K ^b   Lunec, J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Array analysis; Bladder tumours; EGF receptor; EGR1; Gefitinib

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MESSENGER RNA;

ARTICLE; BLADDER TUMOR; CANCER CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; EARLY GROWTH RESPONSE PROTEIN 1; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 33847722249     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603620     Document Type: Article

References (39)

1. Adamson E, de Belle I, Mittal S, Wang Y, Hayakawa J, Korkmaz K, O'Hagan D, McClelland M, Mercola D (2003) Egr1 signaling in prostate cancer. Cancer Biol Ther 2: 617-622
2. Blackledge G, Averbuch S (2004) Gefitinib ('Iressa', ZD1839) and new epidermal growth factor receptor inhibitors. Br J Cancer 90: 566-572
3. Booth C, Harnden P, Trejdosiewicz LK, Scriven S, Selby PJ, Southgate J (1997) Stromal and vascular invasion in an human in vitro bladder cancer model. Lab Invest 76: 843-857
4. Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu CT, Lombari V, Zani M, Giannini G, Gagliardi FM, Caruso R, Gulino A, Frati L, Ragona G (2001) The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res 7: 2788-2796
5. Chen CC, Shieh B, Jin YT, Liau YE, Huang CH, Liou JT, Wu LW, Huang WY, Young KC, Lai MD, Liu HS, Li C (2001) Microarray profiling of gene expression patterns in bladder tumor cells treated with genistein. J Biomed Sci 8: 214-222
6. Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, Chinnaiyan AM, Harari PM (2005) Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Res 65: 3328-3335
7. Chomczynski P, Sacchi N (1987) Single-Step Method of Rna Isolation By Acid Guanidinium Thiocyanate Phenol Chloroform Extraction. Anal Biochem 162: 156-159
8. Cui MZ, Parry GCN, Oeth P, Larson H, Smith M, Huang RP, Adamson ED, Mackman N (1996) Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem 271: 2731-2739
9. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG, Tindall DJ (1998) Expression of early growth response genes in human prostate cancer. Cancer Res 58: 2461-2468
10. Gashler A, Sukhatme VP (1995) Early Growth-Response Protein 1(Egr-1) - Prototype of a Zinc-Finger Family of Transcription Factors. Prog Nucl Acid Res Mol Biol 50: 191-224
11. Herbst RS, Fukuoka M, Baselga J (2004) Timeline - Gefitinib - a novel targeted approach to treating cancer. Nat Rev Cancer 4: 956-965
12. Huang RP, Fan Y, deBelle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED (1997) Decreased EGR-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72: 102-109
13. Kaufmann K, Thiel G (2001) Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells. J Neurol Sci 189: 83-91
14. Kaufmann K, Thiel G (2002) Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem 85: 381-391
15. Krones-Herzig A, Adamson E, Mercola D (2003) Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence. Proc Natl Acad Sci USA 100: 3233-3238
16. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE, Stark GR (1996) Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16: 369-375
17. Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ (1995) Expression patterns of immediate-early transcription factors in human nonsmall cell lungcancer. Oncogene 11: 1261-1269
18. Lipponen P, Eskelinen M (1994) Expression of epidermal growth-factor receptor in bladder-cancer as related to established prognostic factors, oncoprotein (C-Erbb-2, p53) expression and long-term prognosis. Br J Cancer 69: 1120-1125
19. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139
20. Masters JRW, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR, Franks LM (1986) Tissue-culture model of transitional cell-carcinoma - characterization of 22 human urothelial cell-lines. Cancer Res 46: 3630-3636
21. Mellon JK, Cook S, Chambers P, Neal DE (1996) Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor. Br J Cancer 73: 654-658
22. Mellon K, Wright C, Kelly P, Horne CHW, Neal DE (1995) Long-term outcome related to epidermal growth-factor receptor status in bladder-cancer. J Urol 153: 919-925
23. Molnar G, Crozat A, Pardee AB (1994) The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol Cell Biol 14: 5242-5248
24. Mora GR, Olivier KR, Cheville JC, Mitchell Jr RF, Lingle WL, Tindall DJ (2004) The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate. Mol Cancer Res 2: 115-128
25. Neal DE, Bennett MK, Hall RR, Marsh C, Abel PD, Sainsbury JRC, Harris AL (1985) Epidermal-growth-factor receptors in human bladder-cancer - comparison of invasive and superficial tumors. Lancet 1: 366-368
26. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth-factor receptor and the prognosis of bladder-cancer. Cancer 65: 1619-1625
27. Nishi H, Nishi KH, Johnson AC (2002) Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 62: 827-834
28. Nutt JE, Harris AL, Lunec J (1991) Phorbol ester and bryostatin effects on growth and the expression of estrogen responsive and Tgf-beta-1 genes in breast-tumor cells. Br J Cancer 64: 671-676
29. Nutt JE, Lazarowicz HP, Mellon JK, Lunec J (2004) Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2. Br J Cancer 90: 1679-1685
30. Nutt JE, Mellon JK, Qureshi K, Lunec J (1998) Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours. Br J Cancer 78: 215-220
31. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane CJ, Carroll PR, Igawa M, Dahiya R (2005) Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene 24: 6765-6772
32. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167
33. Saadane N, Alpert L, Chalifour LE (2000) Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am J Physiol. Heart Circulatory Physiol 278: H796-H805
34. Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MK, Milbrandt J (2000) EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 275: 38524-38531
35. Thigpen AE, Cala KM, Guileyardo JM, Molberg KH, McConnell JD, Russell DW (1996) Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma. J Urol 155: 975-981
36. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354
37. Wakeling AE, Barker AJ, Davies DH, Brown DS, Green LR, Cartlidge SA, Woodburn JR (1996) Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines. Breast Cancer Res Treatment 38: 67-73
38. Woodburn JR (1999) The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Therapeut 82: 241-250
39. Zhang WS, Du Yan S, Zhu AP, Zou YS, Williams M, Godman GC, Thomashow BM, Ginsburg ME, Stern DM, Yan SF (2000) Expression of Egr-1 in late stage emphysema. Am J Pathol 157: 1311-1320